Development and characterization of CD73-siRNA-loaded nanoemulsion: effect on C6 glioma cells and primary astrocytes

References

• Allard B, Longhi MS, Robson SC, Stagg J. 2017. The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets. Immunol Rev. 276(1):121–144.
   PubMed Web of Science ®Google Scholar
• Allard B, Turcotte M, Stagg J. 2012. CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth. J Biomed Biotechnol. 2012:485156.
   PubMedGoogle Scholar
• Allard D, Chrobak P, Allard B, Messaoudi N, Stagg J. 2018. Targeting the CD73-adenosine axis in immuno-oncology. Immunol Lett. 205:31–39.
   PubMed Web of Science ®Google Scholar
• Azambuja JH, da Silveira EF, de Carvalho TR, Oliveira PS, Pacheco S, de Couto CT, Beira FT, Stefanello FM, Spanevello RM, Braganhol E. 2017. Glioma sensitive or chemoresistant to temozolomide differentially modulate macrophage protumor activities. Biochim Biophys Acta Gen Subj. 1861(11 Pt A):2652–2662.
   PubMed Web of Science ®Google Scholar
• Azambuja JH, Gelsleichter NE, Beckenkamp LR, Iser IC, Fernandes MC, Figueiró F, Battastini AMO, Scholl JN, de Oliveira FH, Spanevello RM, et al. 2018. CD73 downregulation decreases in vitro and in vivo glioblastoma growth. Mol Neurobiol. 56(5):3260–3279.
   PubMed Web of Science ®Google Scholar
• Azambuja JH, Schuh RS, Michels LR, Gelsleichter NE, Beckenkamp LR, Iser IC, Lenz GS, de Oliveira FH, Venturin G, Greggio S, et al. 2019. Nasal administration of cationic nanoemulsions as CD73-siRNA delivery system for Glioblastoma treatment: a new therapeutical approach. Mol Neurobiol. doi:10.1007/s12035-019-01730-6.
   Web of Science ®Google Scholar
• Beavis PA, Stagg J, Darcy PK, Smyth MJ. 2012. CD73: a potent suppressor of antitumor immune responses. Trends Immunol. 33(5):231–237.
   PubMed Web of Science ®Google Scholar
• Boche M, Pokharkar V. 2017. Quetiapine nanoemulsion for intranasal drug delivery: evaluation of brain-targeting efficiency. AAPS PharmSciTech. 18(3):686–696.
   PubMed Web of Science ®Google Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72(1–2):248–254.
   PubMed Web of Science ®Google Scholar
• Bruxel F, Bochot A, Diel D, Wild L, Carvalho ELS, Cojean S, Loiseau PM, Fattal E, Teixeira HF. 2014. Adsorption of antisense oligonucleotides targeting malarial topoisomerase II on cationic nanoemulsions optimized by a full factorial design. Curr Top Med Chem. 14(9):1161–1171.
   PubMed Web of Science ®Google Scholar
• Burnstock G. 2009. Purinergic signalling: past, present and future. Braz J Med Biol Res. 42(1):3–8.
   PubMed Web of Science ®Google Scholar
• Burnstock G, Di Virgilio F. 2013. Purinergic signalling and cancer. Purinergic Signal. 9(4):491–540.
   PubMed Web of Science ®Google Scholar
• Cappellari AR, Vasques GJ, Bavaresco L, Braganhol E, Battastini A. 2012. Involvement of ecto-5′-nucleotidase/CD73 in U138MG glioma cell adhesion. Mol Cell Biochem. 359(1–2):315–322.
   PubMed Web of Science ®Google Scholar
• Chan KM, Delfert D, Junger KD. 1986. A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem. 157(2):375–380.
   PubMed Web of Science ®Google Scholar
• Da Silveira EF, Chassot JM, Teixeira FC, Azambuja JH, Debom G, Beira FT, Del Pino FAB, Lourenço A, Horn AP, Cruz L, et al. 2013. Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme. Invest New Drugs. 31(6):1424–1435.
   PubMed Web of Science ®Google Scholar
• Deng Y, Wang CC, Choy KW, Du Q, Chen J, Wang Q, Li L, Chung TKH, Tang T. 2014. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Gene. 538(2):217–227.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Adinolfi E. 2017. Extracellular purines, purinergic receptors and tumor growth. Oncogene. 36(3):293–303.
   PubMed Web of Science ®Google Scholar
• Fausther M, Lecka J, Soliman E, Kauffenstein G, Pelletier J, Sheung N, Dranoff JA, Sévigny J. 2011. Coexpression of ecto-5′-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver. Am J Physiol Liver Physiol. 302:G447–G459.
   PubMed Web of Science ®Google Scholar
• Ferrari D, McNamee EN, Idzko M, Gambari R, Eltzschig HK. 2016. Purinergic signaling during immune cell trafficking. Trends Immunol. 37(6):399–411.
   PubMed Web of Science ®Google Scholar
• Fraga M, de Carvalho TG, Diel Dda S, Kretzmann Filho NA, Teixeira HF, Matte U. 2015. Cationic nanoemulsions as a gene delivery system: proof of concept in the mucopolysaccharidosis I murine model. J Nanosci Nanotechnol. 15(1):810–816.
   PubMed Web of Science ®Google Scholar
• Franceschi E, Minichillo S, Brandes AA. 2017. Pharmacotherapy of glioblastoma: established treatments and emerging concepts. CNS Drugs. 31(8):675–684.
   PubMed Web of Science ®Google Scholar
• Gallego O. 2015. Nonsurgical treatment of recurrent glioblastoma. Curr Oncol. 22(4):e273–e281.
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu XL, Li XR. 2011. Research progress on siRNA delivery with nonviral carriers. Int J Nanomedicine. 6:1017–1025.
   PubMed Web of Science ®Google Scholar
• Gaudreau PO, Allard B, Turcotte M, Stagg J. 2016. CD73-adenosine reduces immune responses and survival in ovarian cancer patients. Oncoimmunology. 5(5):e1127496.
   PubMed Web of Science ®Google Scholar
• Jadidi-Niaragh F, Atyabi F, Rastegari A, Kheshtchin N, Arab S, Hassannia H, Ajami M, Mirsanei Z, Habibi S, Masoumi F, et al. 2017. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. J Control Release. 246:46–59.
   PubMed Web of Science ®Google Scholar
• Jain S, Pathak K, Vaidya A. 2018. Molecular therapy using siRNA: recent trends and advances of multi target inhibition of cancer growth. Int J Biol Macromol. 116:880–892.
   PubMed Web of Science ®Google Scholar
• Kazemi MH, Raoofi Mohseni S, Hojjat-Farsangi M, Anvari E, Ghalamfarsa G, Mohammadi H, Jadidi-Niaragh F. 2018. Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer. J Cell Physiol. 233(3):2032–2057.
   PubMed Web of Science ®Google Scholar
• Klang V, Matsko NB, Valenta C, Hofer F. 2012. Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment. Micron. 43(2–3):85–103.
   PubMed Web of Science ®Google Scholar
• Koszałka P, Gołuńska M, Stanisławowski M, Urban A, Stasiłojć G, Majewski M, Wierzbicki P, Składanowski AC, Bigda J. 2015. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis. Int J Biochem Cell Biol. 69:1–10.
   PubMed Web of Science ®Google Scholar
• Lima FRS, Kahn SA, Soletti RC, Biasoli D, Alves T, da Fonseca ACC, Garcia C, Romão L, Brito J, Holanda-Afonso R, Faria J, et al. 2012. Glioblastoma: therapeutic challenges, what lies ahead. Biochim Biophys Acta. 1826(2):338–349.
   PubMed Web of Science ®Google Scholar
• Loi S, Darcy PK, Beavis PA, Smyth MJ, Haibe-Kains B, Pommey S, Stagg J. 2013. CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer. Proc Natl Acad Sci USA. 110(27):11091–11096.
   PubMed Web of Science ®Google Scholar
• Maduri S. 2015. Applicability of RNA interference in cancer therapy: current status. Superior vena cava syndrome: initial presentation of acute myeloid leukemia in a child. Indian J Cancer . 52(1):11.
   PubMed Web of Science ®Google Scholar
• Malhotra M, Toulouse A, Godinho BMDC, McCarthy DJ, Cryan JF, O’Driscoll CM. 2015. RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies. Mol Biosyst. 11(10):2635–2657.
   PubMedGoogle Scholar
• Martini E, Fattal E, de Oliveira MC, Teixeira H. 2008. Effect of cationic lipid composition on properties of oligonucleotide/emulsion complexes: physico-chemical and release studies. Int J Pharm. 352(1–2):280–286.
   PubMed Web of Science ®Google Scholar
• Pacheco SM, Azambuja JH, de Carvalho TR, Soares MSP, Oliveira PS, da Silveira EF, Stefanello FM, Braganhol E, Gutierres JM, Spanevello RM. 2018. Glioprotective effects of lingonberry extract against altered cellular viability, acetylcholinesterase activity, and oxidative stress in lipopolysaccharide-treated astrocytes. Cell Mol Neurobiol. 38(5):1107–1121.
   PubMed Web of Science ®Google Scholar
• Perry A, Ellison DW, Reifenberger G, Kleihues P, Von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Louis DN. 2016. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131:803–820.
   PubMed Web of Science ®Google Scholar
• Pommey S, Dwyer KM, Divisekera U, Sharkey J, Denoyer D, Stagg J, Smyth MJ, McLaughlin N. 2010. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci USA. 107:1547–1552.
   PubMed Web of Science ®Google Scholar
• Quezada C, Garrido W, Oyarzún C, Fernández K, Segura R, Melo R, Casanello P, Sobrevia L, San Martín R. 2013. 5′-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells. J Cell Physiol. 228(3):602–608.
   PubMed Web of Science ®Google Scholar
• Schuh RS, Carvalho TG, Giugliani R, Matte U, Baldo G, Teixeira HF. 2018. Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers. Eur J Pharm Biopharm. 122:158–166.
   PubMed Web of Science ®Google Scholar
• Stagg J, Allard B, Turcotte M, Spring K, Pommey S, Royal I. 2013. Anti-CD73 therapy impairs tumor angiogenesis. Int J Cancer. 134:1466–1473.
   PubMed Web of Science ®Google Scholar
• Teixeira H, Fraga F, Bruxel VL, Lagranha HF, Matte U. 2011. Influence of phospholipid composition on cationic emulsions/DNA complexes: physicochemical properties, cytotoxicity, and transfection on Hep G2 cells. Int J Nanomedicine. 6:2213–2220..
   PubMed Web of Science ®Google Scholar
• Teixeira HF, Bruxel F, Fraga M, Schuh RS, Zorzi GK, Matte U, Fattal E. 2017. Cationic nanoemulsions as nucleic acids delivery systems. Int J Pharm. 534(1–2):356–367.
   PubMed Web of Science ®Google Scholar
• Terp MG, Olesen KA, Arnspang EC, Lund RR, Lagerholm BC, Ditzel HJ, Leth-Larsen R. 2013. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells. J Immunol. 191(8):4165–4173.
   PubMed Web of Science ®Google Scholar
• Trimaille T, Chaix C, Pichot C, Delair T. 2003. Polymer functionalized submicrometric emulsions as potential synthetic DNA vectors. J Colloid Interface Sci. 258(1):135–145.
   PubMed Web of Science ®Google Scholar
• Ui-Tei K. 2016. Is the efficiency of RNA silencing evolutionarily regulated? Int J Mol Sci. 17:719.
   Web of Science ®Google Scholar
• Wang H, Lee S, Lo Nigro C, Lattanzio L, Merlano M, Monteverde M, Matin R, Purdie K, Mladkova N, Bergamaschi D, et al. 2012. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity. Br J Cancer. 106(8):1446–1452.
   PubMed Web of Science ®Google Scholar
• Wang X, Song B, Chang X.-S, Zhang X, Zhang B, Pang T, Fang G-E, Yin K. 2015. The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma. Tumor Biol. 36:5459–5466.
   PubMedGoogle Scholar
• Yi GZ, Xiang W, Feng WY, Chen ZY, Li YM, Deng SZ, Guo ML, Zhao L, Sun XG, He MY, et al. 2018. Identification of key candidate proteins and pathways associated with temozolomide resistance in glioblastoma based on subcellular proteomics and bioinformatical analysis. Biomed Res Int. 2018:5238760.
   PubMed Web of Science ®Google Scholar
• Young A, Mittal D, Stagg J, Smyth MJ. 2014. Targeting cancer-derived adenosine: new therapeutic approaches. Cancer Discov. 4(8):879–888.
   PubMed Web of Science ®Google Scholar
• Zhi X, Chen S, Zhou P, Shao Z, Wang L, Ou Z, Yin L. 2007. RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin Exp Metastasis. 24(6):439–448.
   PubMed Web of Science ®Google Scholar
• Zhi X, Wang Y, Zhou X, Yu J, Jian R, Tang S, Yin L, Zhou P. 2010. RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells. Cancer Sci. 101(12):2561–2569.
   PubMed Web of Science ®Google Scholar